Cargando…

Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia

BACKGROUND: Current outcome predictors based on "molecular profiling" rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xinan, Huang, Yong, Chen, James L, Xie, Jianming, Sun, Xiao, Lussier, Yves A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745693/
https://www.ncbi.nlm.nih.gov/pubmed/19761576
http://dx.doi.org/10.1186/1471-2105-10-S9-S6
_version_ 1782171987910590464
author Yang, Xinan
Huang, Yong
Chen, James L
Xie, Jianming
Sun, Xiao
Lussier, Yves A
author_facet Yang, Xinan
Huang, Yong
Chen, James L
Xie, Jianming
Sun, Xiao
Lussier, Yves A
author_sort Yang, Xinan
collection PubMed
description BACKGROUND: Current outcome predictors based on "molecular profiling" rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to predict outcome in patients – a paradigm shift towards accurate "mechanism-anchored profiling". We propose a novel algorithm, PGnet, which predicts a tripartite mechanism-anchored network associated to epigenetic regulation consisting of phenotypes, genes and mechanisms. Genes termed as GEMs in this network meet all of the following criteria: (i) they are co-expressed with genes known to be involved in the biological mechanism of interest, (ii) they are also differentially expressed between distinct phenotypes relevant to the study, and (iii) as a biomodule, genes correlate with both the mechanism and the phenotype. RESULTS: This proof-of-concept study, which focuses on epigenetic mechanisms, was conducted in a well-studied set of 132 acute lymphoblastic leukemia (ALL) microarrays annotated with nine distinct phenotypes and three measures of response to therapy. We used established parametric and non parametric statistics to derive the PGnet tripartite network that consisted of 10 phenotypes and 33 significant clusters of GEMs comprising 535 distinct genes. The significance of PGnet was estimated from empirical p-values, and a robust subnetwork derived from ALL outcome data was produced by repeated random sampling. The evaluation of derived robust network to predict outcome (relapse of ALL) was significant (p = 3%), using one hundred three-fold cross-validations and the shrunken centroids classifier. CONCLUSION: To our knowledge, this is the first method predicting co-expression networks of genes associated with epigenetic mechanisms and to demonstrate its inherent capability to predict therapeutic outcome. This PGnet approach can be applied to any regulatory mechanisms including transcriptional or microRNA regulation in order to derive predictive molecular profiles that are mechanistically anchored. The implementation of PGnet in R is freely available at .
format Text
id pubmed-2745693
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27456932009-09-18 Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia Yang, Xinan Huang, Yong Chen, James L Xie, Jianming Sun, Xiao Lussier, Yves A BMC Bioinformatics Proceedings BACKGROUND: Current outcome predictors based on "molecular profiling" rely on gene lists selected without consideration for their molecular mechanisms. This study was designed to demonstrate that we could learn about genes related to a specific mechanism and further use this knowledge to predict outcome in patients – a paradigm shift towards accurate "mechanism-anchored profiling". We propose a novel algorithm, PGnet, which predicts a tripartite mechanism-anchored network associated to epigenetic regulation consisting of phenotypes, genes and mechanisms. Genes termed as GEMs in this network meet all of the following criteria: (i) they are co-expressed with genes known to be involved in the biological mechanism of interest, (ii) they are also differentially expressed between distinct phenotypes relevant to the study, and (iii) as a biomodule, genes correlate with both the mechanism and the phenotype. RESULTS: This proof-of-concept study, which focuses on epigenetic mechanisms, was conducted in a well-studied set of 132 acute lymphoblastic leukemia (ALL) microarrays annotated with nine distinct phenotypes and three measures of response to therapy. We used established parametric and non parametric statistics to derive the PGnet tripartite network that consisted of 10 phenotypes and 33 significant clusters of GEMs comprising 535 distinct genes. The significance of PGnet was estimated from empirical p-values, and a robust subnetwork derived from ALL outcome data was produced by repeated random sampling. The evaluation of derived robust network to predict outcome (relapse of ALL) was significant (p = 3%), using one hundred three-fold cross-validations and the shrunken centroids classifier. CONCLUSION: To our knowledge, this is the first method predicting co-expression networks of genes associated with epigenetic mechanisms and to demonstrate its inherent capability to predict therapeutic outcome. This PGnet approach can be applied to any regulatory mechanisms including transcriptional or microRNA regulation in order to derive predictive molecular profiles that are mechanistically anchored. The implementation of PGnet in R is freely available at . BioMed Central 2009-09-17 /pmc/articles/PMC2745693/ /pubmed/19761576 http://dx.doi.org/10.1186/1471-2105-10-S9-S6 Text en Copyright © 2009 Yang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Yang, Xinan
Huang, Yong
Chen, James L
Xie, Jianming
Sun, Xiao
Lussier, Yves A
Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title_full Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title_fullStr Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title_full_unstemmed Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title_short Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
title_sort mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745693/
https://www.ncbi.nlm.nih.gov/pubmed/19761576
http://dx.doi.org/10.1186/1471-2105-10-S9-S6
work_keys_str_mv AT yangxinan mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia
AT huangyong mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia
AT chenjamesl mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia
AT xiejianming mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia
AT sunxiao mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia
AT lussieryvesa mechanismanchoredprofilingderivedfromepigeneticnetworkspredictsoutcomeinacutelymphoblasticleukemia